News& Information
Home -> News& InformationOn October 19, China's State Food and Drug Administration approved Pfizer's Class 1 innovative drug Ritlecitinib Tosylate Capsules (als
For details >>Seasonal Allergy - What Should You Know?
For details >>Medical Chaperon Service
For details >>International Women's Day Celebration With FinnCham
For details >>